General form of registration statement for all companies including face-amount certificate companies

NOTES PAYABLE (Details Narrative)

v3.10.0.1
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 15, 2016
Mar. 15, 2016
Jul. 07, 2014
Jan. 26, 2018
Jun. 30, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2018
Mar. 21, 2016
Notes payable balance           $ 172,748   $ 246,337 $ 54,155
Interest expense       $ 25,500            
Unpaid balance               $ 942,596    
Unsecured promissory notes     $ 545,218              
Interest rate     12.00% 8.00%            
Monthly payments     $ 10,658              
Common stock, shares issued       100,000   244,086,285 181,804,501   247,186,285  
Deposits applied as payment on note payable               $ 57,404    
Termination of licensing agreement           $ 132,804      
Original issuance discount           $ 11,250 11,250   $ 11,250  
Principal and interest due date       Jul. 26, 2018            
Note 1 [Member]                    
Unsecured promissory notes       $ 250,000            
Note 2 [Member]                    
Unsecured promissory notes       $ 250,000            
Loan [Member]                    
Interest expense $ 17,970                  
Common stock, shares issued 300,000                  
Naltrexone Implant Formulation [Member]                    
Interest expense             60,000      
Aggregate purchase price         $ 1,132,000   1,132,000      
Payment obligation             $ 1,000,000      
Period of obligation             14 months      
Licensing Agreements [Member]                    
Termination of licensing agreement             $ 132,804      
Secured Promissory Note [Member]                    
Secured promissory note   $ 360,000                
Issuance period   90 days                
Proceeds received   $ 300,000                
Original issuance discount   $ 60,000